Duramune LymeThis page contains information on Duramune Lyme for veterinary use.
The information provided typically includes the following:
- Duramune Lyme Indications
- Warnings and cautions for Duramune Lyme
- Direction and dosage information for Duramune Lyme
Duramune LymeThis treatment applies to the following species:
Borrelia Burgdorferi Bacterin
For use in dogs only
Duramune Lyme Indications
This product has been shown to be effective for the vaccination of healthy dogs nine weeks of age or older against Borrelia burgdorferi. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
StorageStore in the dark between 35 - 46°F (2 - 8°C). Avoid freezing.
Preservative: Thimerosal. May contain residual amounts of formalin.
Dosage and AdministrationUsing aseptic technique, inject a 1 mL dose subcutaneously. A second dose should be administered 2 to 3 weeks later. Annual revaccination with one dose is recommended.
PrecautionsShake well before using. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products, except as specified on this label. This product has not been tested in pregnant animals. In case of human exposure, contact a physician.
Duramune Lyme Caution
In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.
Duramune Lyme, Elanco and the diagonal bar logo are trademarks of Eli Lilly and Company or its affiliates.
© 2017 Elanco US Inc. all rights reserved.
Elanco US Inc., Fort Dodge, Iowa 50501
25 x 1 mL vials of vaccine
FORT DODGE, IA, 50501
|Every effort has been made to ensure the accuracy of the Duramune Lyme information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-02-26